secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001628280-25-031559
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo stockholders approve 14M share increase to 2018 equity plan
-------------------------------------------------------------------

- Share reserve increased by 14,000,000 shares; total now includes 8.8M, 9.9M, 7.9M, 10M, 11M from prior years.
- Incentive stock option limit raised to 123,200,000 shares.
- All nine director nominees elected, including Courtney Beers, Kenneth Hillan, and H. Stewart Parker.
- Advisory say-on-pay approved: 32.8M for, 23.2M against, 1.3M abstentions.
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 119.6M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000162828025031559/0001628280-25-031559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000162828025031559/sgmo-20250612.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-031559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer